Self-management of Patients With Acute Coronary Syndromes

Status Enrolling by invitation

Clinical Trial Summary

Purpose : The purpose of this study is to investigate the tracking effect of selfmanagement programs on anxiety, depression, and quality of life in patients with Acute Coronary Syndromes (ACS).

Clinical Trial Description

Research Design : This study the first phase is to construct and develop interventional measures for self-management of patients with ACS. According to the associated factors of study, the intervention measures are designed based on self-management. A pilot study will be conducted to improve research and to develop better selfmanagement interventions in the future. At the secondary stage: a randomized controlled trial with a random sampling design is used to investigate the effects of self-management programs on anxiety, depression, and quality of life in patients with ACS. The study will conduct in a cardiac medicine ward or coronary intensive care center of a north medical center. Patients with ACS,who met the conditions and agreed to join the study will be recruited. Then,the informed consent will be obtained. At the first stage, 10subjects will be collect. At the secondary stage, a total of 104 subjects will be enrolled, 52 in the experimental group will receive the self-management program, and 52 in the control group will receive a routine hospital care. Method & Results: The data of demographic and disease characteristics, clinical indicators,depression, anxiety, self-management, and quality of life will be collected.The Hospital Anxiety and Depression Scale, the SF-36 Taiwan version of the Quality-of-Life Questionnaire and the Self-Management Scale will used as tools to collect data. The efficacy of the intervention will be collected 1 month and 3 months after the intervention. Data will be statistically analyzed by GEE. Hypothesis : It is expected that the self-management program applied to patients with ACS can reduce depression and anxiety, thereby improving the quality of life. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05999695
Study type	Interventional
Source	Taipei Veterans General Hospital, Taiwan
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	December 11, 2022
Completion date	August 26, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02552407` - Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis	N/A
Completed	`NCT01398228` - Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3	N/A
Completed	`NCT01135667` - Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI	Phase 4
Recruiting	`NCT02592720` - Cocktail Injection Improves Outcomes of FFR Guided PCI	Phase 4
Completed	`NCT01641510` - PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants	Phase 3
Completed	`NCT01743274` - Does Optical Coherence Tomography Optimise Results of Stenting	N/A
Active, not recruiting	`NCT01433627` - Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX	Phase 3
Completed	`NCT01452282` - Ankle-Brachial Index Estimating Cardiac Complications After Surgery	N/A
Recruiting	`NCT01418794` - Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease	Phase 4
Recruiting	`NCT01000701` - Inflammation and Acute Coronary Syndromes	N/A
Terminated	`NCT01107899` - Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes	Phase 1
Completed	`NCT00494247` - Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes	Phase 4
Terminated	`NCT00615719` - Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation	N/A
Active, not recruiting	`NCT06089343` - High-risk Features of Coronary Lesions in CTA and OCT
Not yet recruiting	`NCT04023630` - DUAL Antithrombotic Therapy in Patients With AF and ACS	Phase 4
Recruiting	`NCT02601404` - REal World Advanced Experience of BioResorbable ScaffolD by SMart Angioplasty Research Team (SMART REWARD)	N/A
Completed	`NCT02195193` - Integrating Depression Care in Acute Coronary Syndromes Care in China	N/A
Completed	`NCT02141750` - THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES	N/A
Not yet recruiting	`NCT01735227` - Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)	Phase 4
Completed	`NCT00097591` - A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.